Table of Contents

1. Introduction

 1.1 Newborn Screening Market Definition & Scope

 1.2 Research Assumptions & Abbreviations

 1.3 Research Methodology

2. Executive Summary

 2.1 Newborn Screening Market Snapshot

 2.2 Newborn Screening Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2035

 2.3 Newborn Screening Market Size & Forecast, By Segmentation, 2022–2035

  2.3.1 Newborn Screening Market Size By Test Type

  2.3.2 Newborn Screening Market Size By Technology

  2.3.3 Newborn Screening Market Size By Product Type

  2.3.4 Newborn Screening Market Size By Application

 2.4 Newborn Screening Market Share & Bps Analysis By Region, 2025

 2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic

 2.6 Industry CxO’s Perspective

3. Newborn Screening Market Overview

 3.1 Newborn Screening Market Dynamics

  3.1.1 Drivers

  3.1.2 Restraints

  3.1.3 Opportunities

  3.1.4 Key Newborn Screening Market Trends

 3.2 Industry PESTLE Analysis

 3.3 Key Industry Forces (Porter’s) Impacting Newborn Screening Market Growth

 3.4 Industry Supply Chain Analysis

  3.4.1 Raw Material Suppliers

  3.4.2 Manufacturers

  3.4.3 Distributors/Suppliers

  3.4.4 Hospitals & Diagnostic Labs (End-Users)

 3.5 Industry Life Cycle Assessment

 3.6 Parent Newborn Screening Market Overview

 3.7 Newborn Screening Market Risk Assessment

4. Statistical Insights & Trends Reporting

4.1 Screening Coverage & Penetration Analysis

  4.1.1 Overview

  4.1.2 National Newborn Screening Coverage Rates by Region (Developed vs. Developing)

  4.1.3 Number of Conditions Screened by Country (Core Panel vs. Expanded Panel)

  4.1.4 Birth Rate-Adjusted Screening Volumes (2022–2035)

  4.1.5 Regional Disparities in Screening Accessibility & Infrastructure Gaps

4.2 Regulatory & Reimbursement Landscape

  4.2.1 Overview

  4.2.2 Mandatory Newborn Screening Guidelines by Health Authorities (CDC, WHO, EMA, FDA)

  4.2.3 Reimbursement Frameworks for NBS Tests (Public Health Funding vs. Private Insurance)

  4.2.4 Compliance with CLIA, ISO, and In Vitro Diagnostic Regulation (IVDR)

  4.2.5 Strategic Guidelines for Laboratory Accreditation & Quality Assurance

4.3 Technology & Innovation Metrics

  4.3.1 Overview

  4.3.2 Adoption Rate of Tandem Mass Spectrometry (TMS) vs. NGS in Public Health Labs

  4.3.3 Investment in Point-of-Care Newborn Screening Devices

  4.3.4 Patent Filings and Technological Innovations in Dried Blood Spot (DBS) Analysis

  4.3.5 Emerging Trends: AI-Based Disease Prediction, Rapid Genetic Sequencing, Tele-NBS

4.4 Operational & Diagnostic Metrics

  4.4.1 Overview

  4.4.2 Number of Newborns Screened Annually (Global & Regional)

  4.4.3 False Positive Rates and Confirmatory Testing Turnaround Times

  4.4.4 Laboratory Throughput and Automation Levels by Facility Type

  4.4.5 Disease Prevalence Detected via NBS (PKU, CH, SCD, CF, MCADD, etc.)

4.5 Investment & Strategic Activity

  4.5.1 Overview

  4.5.2 Government Funding & Public-Private Partnerships in Newborn Screening Programs

  4.5.3 Key M&A Activity and Strategic Partnerships (Diagnostic Companies & Research Institutes)

  4.5.4 Collaborations Between Reagent Kits Manufacturers and Hospital Networks

  4.5.5 Emerging Innovation Hubs and R&D Centers for Rare Disease Newborn Detection

5. Newborn Screening Market Segmental Analysis & Forecast, By Test Type, 2022–2035, Value (USD Billion)

5.1 Introduction

 5.2 Dry Blood Spot (DBS) Tests

  5.2.1 Key Trends

  5.2.2 Newborn Screening Market Size & Forecast, 2022–2035

 5.3 Hearing Screening

 5.4 Critical Congenital Heart Disease (CCHD) Screening

 5.5 DNA-based / Genetic Screening

6. Newborn Screening Market Segmental Analysis & Forecast, By Technology, 2022–2035, Value (USD Billion)

    6.1 Introduction

 6.2 Tandem Mass Spectrometry (TMS)

  6.2.1 Key Trends

  6.2.2 Newborn Screening Market Size & Forecast, 2022–2035

 6.3 PCR / Molecular Assays

 6.4 Immunoassays (ELISA, FIA, etc.)

 6.5 Next-Generation Sequencing (NGS)

7. Newborn Screening Market Segmental Analysis & Forecast, By Product Type, 2022–2035, Value (USD Billion)

    7.1 Introduction

 7.2 Reagents & Assay Kits

  7.2.1 Key Trends

  7.2.2 Newborn Screening Market Size & Forecast, 2022–2035

 7.3 Instruments / Analyzers

 7.4 Hearing Screening Devices

 7.5 Consumables & Accessories

8. Newborn Screening Market Segmental Analysis & Forecast, By Application, 2022–2035, Value (USD Billion)

    8.1 Introduction

 8.2 Metabolic Disorders

  8.2.1 Key Trends

  8.2.2 Newborn Screening Market Size & Forecast, 2022–2035

 8.3 Hormonal Disorders

 8.4 Hematological Disorders

 8.5 Hearing & CCHD Disorders

 8.6 Genetic / Rare Diseases

9. Newborn Screening Market Segmental Analysis & Forecast By Region, 2022–2035, Value (USD Billion)

9.1 Introduction

9.2 North America

 9.2.1 Key Trends

 9.2.2 Newborn Screening Market Size & Forecast, By Test Type, 2022–2035

 9.2.3 Newborn Screening Market Size & Forecast, By Technology, 2022–2035

 9.2.4 Newborn Screening Market Size & Forecast, By Product Type, 2022–2035

 9.2.5 Newborn Screening Market Size & Forecast, By Application, 2022–2035

 9.2.6 Newborn Screening Market Size & Forecast, By Country, 2022–2035

  9.2.6.1 USA

  9.2.6.2 Canada

9.3 Europe

 9.3.1 Key Trends

 9.3.2 Newborn Screening Market Size & Forecast, By Test Type, 2022–2035

 9.3.3 Newborn Screening Market Size & Forecast, By Technology, 2022–2035

 9.3.4 Newborn Screening Market Size & Forecast, By Product Type, 2022–2035

 9.3.5 Newborn Screening Market Size & Forecast, By Application, 2022–2035

 9.3.6 Newborn Screening Market Size & Forecast, By Country, 2022–2035

  9.3.6.1 Germany

  9.3.6.2 UK

  9.3.6.3 France

  9.3.6.4 Italy

  9.3.6.5 Spain

  9.3.6.6 Russia

  9.3.6.7 Poland

  9.3.6.8 Rest of Europe

9.4 Asia-Pacific

 9.4.1 Key Trends

 9.4.2 Newborn Screening Market Size & Forecast, By Test Type, 2022–2035

 9.4.3 Newborn Screening Market Size & Forecast, By Technology, 2022–2035

 9.4.4 Newborn Screening Market Size & Forecast, By Product Type, 2022–2035

 9.4.5 Newborn Screening Market Size & Forecast, By Application, 2022–2035

 9.4.6 Newborn Screening Market Size & Forecast, By Country, 2022–2035

  9.4.6.1 China

  9.4.6.2 India

  9.4.6.3 Japan

  9.4.6.4 South Korea

  9.4.6.5 Australia

  9.4.6.6 ASEAN Countries

  9.4.6.7 Rest of Asia-Pacific

9.5 Latin America

 9.5.1 Key Trends

 9.5.2 Newborn Screening Market Size & Forecast, By Test Type, 2022–2035

 9.5.3 Newborn Screening Market Size & Forecast, By Technology, 2022–2035

 9.5.4 Newborn Screening Market Size & Forecast, By Product Type, 2022–2035

 9.5.5 Newborn Screening Market Size & Forecast, By Application, 2022–2035

 9.5.6 Newborn Screening Market Size & Forecast, By Country, 2022–2035

  9.5.6.1 Brazil

  9.5.6.2 Argentina

  9.5.6.3 Mexico

  9.5.6.4 Colombia

  9.5.6.5 Rest of Latin America

9.6 Middle East & Africa

 9.6.1 Key Trends

 9.6.2 Newborn Screening Market Size & Forecast, By Test Type, 2022–2035

 9.6.3 Newborn Screening Market Size & Forecast, By Technology, 2022–2035

 9.6.4 Newborn Screening Market Size & Forecast, By Product Type, 2022–2035

 9.6.5 Newborn Screening Market Size & Forecast, By Application, 2022–2035

 9.6.6 Newborn Screening Market Size & Forecast, By Country, 2022–2035

  9.6.6.1 UAE

  9.6.6.2 Saudi Arabia

  9.6.6.3 Qatar

  9.6.6.4 Egypt

  9.6.6.5 South Africa

  9.6.6.6 Rest of Middle East & Africa

10. Competitive Landscape

 10.1 Key Players' Positioning

 10.2 Competitive Developments

  10.2.1 Key Strategies Adopted (%), By Key Players, 2025

  10.2.2 Year-Wise Strategies & Development, 2022–2025

  10.2.3 Number Of Strategies Adopted By Key Players, 2025

 10.3 Newborn Screening Market Share Analysis, 2025

 10.4 Product/Service & Application Benchmarking

  10.4.1 Product/Service Specifications & Features By Key Players

  10.4.2 Product/Service Heatmap By Key Players

  10.4.3 Application Heatmap By Key Players

 10.5 Industry Start-Up & Innovation Landscape

10.6 Key Company Profiles

10.6.1 PerkinElmer, Inc.

 10.6.1.1 Company Overview & Snapshot

 10.6.1.2 Product/Service Portfolio

 10.6.1.3 Key Company Financials

 10.6.1.4 SWOT Analysis

10.6.2 Natus Medical Incorporated

10.6.3 Bio-Rad Laboratories, Inc.

10.6.4 GE Healthcare

10.6.5 Thermo Fisher Scientific Inc.

10.6.6 Agilent Technologies, Inc.

10.6.7 Waters Corporation

10.6.8 Trivitron Healthcare

10.6.9 Baebies, Inc.

10.6.10 Medtronic plc

10.6.11 Masimo Corporation

10.6.12 Zentech S.A.

10.6.13 Demant A/S

10.6.14 Hill-Rom Holdings, Inc.

10.6.15 Revvity

10.6.16 Natera, Inc.

10.6.17 OZ Systems

10.6.18 Abionic SA

10.6.19 Metascreen

10.6.20 Cordlife Group Limited

11. Analyst Recommendations

 11.1 SNS Insider Opportunity Map

 11.2 Industry Low-Hanging Fruit Assessment

 11.3 Newborn Screening Market Entry & Growth Strategy

 11.4 Analyst Viewpoint & Suggestions on Newborn Screening Market Growth

12. Assumptions

13. Disclaimer

14. Appendix

 14.1 List Of Tables

 14.2 List Of Figures